India calls for IP waiver to combat COVID-19
02-03-2021
LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission
01-02-2021
Indian drugmaker joins race to find COVID-19 vaccine
17-02-2020
Anton Balazh / Shutterstock.com
India has granted emergency approval to COVID-19 vaccines developed by AstraZeneca and Oxford University and one from the state-run institute Bharat Biotech, ahead of a huge immunisation drive that is planned to begin this week.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
India, COVID-19, AstraZeneca, Oxford University, Bharat Biotech, Johns Hopkins University
